{"organizations": [], "uuid": "c54ef390484c524bad1e35c89de45311f995a29c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180419.html", "section_title": "Archive News &amp; Video for Thursday, 19 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-gw-pharma-says-presenting-cbd-os-p/brief-gw-pharma-says-presenting-cbd-os-product-in-advisory-committee-meeting-with-fda-on-april-19-idUSFWN1RW0H2", "country": "US", "domain_rank": 408, "title": "BRIEF-GW Pharma Says Presenting CBD-OS Product In Advisory Committee Meeting With FDA On April 19", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.037, "site_type": "news", "published": "2018-04-19T18:27:00.000+03:00", "replies_count": 0, "uuid": "c54ef390484c524bad1e35c89de45311f995a29c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-gw-pharma-says-presenting-cbd-os-p/brief-gw-pharma-says-presenting-cbd-os-product-in-advisory-committee-meeting-with-fda-on-april-19-idUSFWN1RW0H2", "ord_in_thread": 0, "title": "BRIEF-GW Pharma Says Presenting CBD-OS Product In Advisory Committee Meeting With FDA On April 19", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "gw pharmaceuticals", "sentiment": "negative"}, {"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-gw pharma says presenting cbd-os product in advisory committee", "sentiment": "negative"}, {"name": "gw pharmaceuticals plc", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 19 (Reuters) - GW Pharmaceuticals PLC:\n* GW PHARMACEUTICALS SAYS PRESENTING CBD-OS PRODUCT (EPIDIOLEX) IN ADVISORY COMMITTEE MEETING WITH FDA ON APRIL 19 - SEC FILING Source text: ( bit.ly/2HK1BW3 ) Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://bit.ly/2HK1BW3", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://www.youtube.com/user/ReutersVideo", "https://instagram.com/reuters/"], "published": "2018-04-19T18:27:00.000+03:00", "crawled": "2018-04-20T12:11:05.003+03:00", "highlightTitle": ""}